Starting this month, June 2018 CTA Focus will cover worldwide clinical trials negotiation based on new strategic alliance with AstraCrux Clinical Trail and Consulting Inc.

Clinical Trial Agreements FOCUS (CTA FOCUS), a Romanian based company with global clinical research services has announced today their strategic alliance with AstraCrux Clinical Trail and Consulting Inc., a Taiwan based company specialized in clinical trial negotiation providing as well as providing medical science consulting, including product development strategies and clinical trial planning and design, as well as specialist training.

​This international strategic alliance which had been concluded on 15^th of May 2018 will provide the possibility to CTA to develop clinical trials in global clinical trials in the new preferred destination Asia, covering up contract negotiations in Asia – Pacific area, Taiwan, China, Hong Kong, Philippines, Australia, Singapore, South Korea, Japan, Vietnam and Thailand and Malaysia.

Asia’s clinical trial industry is in a state of permanent growth due to factors such as highly skilled investigators, robust clinical infrastructure, faster time to recruit patients and cost efficiencies. On the other hand, due to this important strategic partnership Astracrux, by the other hand will have the possibility to enter with clinical trial negotiation and budget negotiation in the European and North American Market.

The alliance is an expression of the global approach of both parties in services in the pharmaceutical industry, including medical science consulting, research contracts negotiation, and will extend into covering further legal services the pharmaceutical area.

The two companies are very glad as this strategic alliance will improve global clinical trials efficiency and change lives of many patients in the forthcoming years.

For more details about the two companies please visit www.ctafocus.com or www.astracrux.biz.

Elisa Toma CHIEF EXECUTIVE OFFICER Email: elisa.toma@ctafocus.com